Friday, January 6, 2006

Parker College Debuts the Drugless Research Hall of Fame

Parker College Debuts the Drugless Research Hall of Fame

The Drugless Research Hall of Fame, founded by Parker College of Chiropractic, honored Dr. Ron Rupert, dean of Research at Parker College, as the first inductee during the first annual Parker Gala held at the 2009 Las Vegas Parker Seminar. The Drugless Research Hall of Fame is an innovative recognition platform designed to showcase significant drug-free contributions in research worldwide.

Las Vegas, NV (PRWEB) February 25, 2009

The Drugless Research Hall of Fame, founded by Parker College of Chiropractic, honored Dr. Ron Rupert, dean of Research at Parker College, as the first inductee during the first annual Parker Gala held at the 2009 Las Vegas Parker Seminar. The Drugless Research Hall of Fame is an innovative recognition platform designed to showcase significant drug-free contributions in research worldwide.

"It is imperative for the profession to support chiropractic research, which will in turn impact patient outcomes, and the growth of the profession," said Dr. Fabrizio Mancini, president of Parker College of Chiropractic.

The Parker Research Institute has become one of the most prestigious research publishers, seeking to position itself as a global leader in chiropractic wellness research. The institute has been widely recognized through publications for its exemplary work in peer-review journals and with various honors including the 2005 World Federation of Chiropractic award for the best scientific research. It has been able to establish extensive collaborative research relationships with both the chiropractic and medical communities and will continue to leverage these relationships in the best interest of the profession.

"Our ties and growing relationships with research centers in countries like China, Spain, and Mexico provide unique research opportunities," said Dr. Rupert. "We will sustain our efforts to involve field doctors and support them by building the research they need for evidence based practice."

Research establishes credibility, plays a pivotal role in today's health care policy, and has a crucial role in issues of reimbursement. The lack of research in many areas diminishes the proper role and compensation of the chiropractic profession. The profession has a serious need for research, in areas spanning from the care of children to that of the aged, from treatment to prevention, from basic science to clinical science, and from visceral issues to somatic conditions, to name a few.

Relationships to establish collaborative research are important and should be fostered in the best interest of the profession. Some of the key research efforts for which funding is required include practice-based research, which involves participation of field doctors and "real" patients in order to document clinical effectiveness, patient satisfaction, and other outcomes; and basic science research, which deals with the physiological effects a spinal adjustment has provided a profound understanding of one mechanism by which chiropractic care helps patients. It also explores models of the vertebral subluxation.

If you are interested in contributing financially to support chiropractic wellness research, please contact Lisa A. Fellers by phone at (214) 902-3482 or by email at lfellers (at) parkercc. edu.

###

Society of American Gastrointestinal and Endoscopic Surgeons to Present the SAGES 2009 Scientific Session and Postgraduate Courses in April 2009

Society of American Gastrointestinal and Endoscopic Surgeons to Present the SAGES 2009 Scientific Session and Postgraduate Courses in April 2009

The Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) will convene its 2009 Scientific Session and Postgraduate Courses in Phoenix, Arizona from April 22-25, 2009. The SAGES Annual Meeting has been the pre-eminent meeting for minimally invasive surgery for the past twenty-eight years. The meeting is expected to draw more than 2,000 surgeons, surgeons-in-training, GI assistants, nurses and other allied health professionals who are interested in minimally invasive surgery and gastrointestinal surgery. The 2009 Program Chair is L. Michael Brunt, MD, from the Washington University School of Medicine in St. Louis, Missouri.

Los Angeles, California (PRWEB) March 1, 2009

The Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) will convene its 2009 Scientific Session and Postgraduate Courses in Phoenix, Arizona from April 22-25, 2009.

The SAGES Annual Meeting has been the pre-eminent meeting for minimally invasive surgery for the past twenty-eight years. The meeting is expected to draw more than 2,000 surgeons, surgeons-in-training, GI assistants, nurses and other allied health professionals who are interested in minimally invasive surgery and gastrointestinal surgery. The 2009 Program Chair is L. Michael Brunt, MD, from the Washington University School of Medicine in St. Louis, Missouri.

The scientific program has been carefully designed to incorporate many of the scientific and technical advances from the leading experts in the fields of general, gastrointestinal, endoscopic and minimally invasive surgery. The program begins on Wednesday, April 22, 2009 with a variety of half-day postgraduate and hands-on courses on such topics as colorectal, hernia, flexible endoscopy, endolumenal/NOTES®, bariatric, laparoscopic cholecystectomy and the Fundamentals of Laparoscopic Surgery (FLS). Wednesday also features the SAGES Education and Research Foundation Awards Luncheon, recognizing distinguished leaders for their work in minimally invasive surgery and helped to keep patient safety and MIS in the forefront. Thursday, April 23, 2009 continues with more courses on foregut and advanced laparoscopic techniques, a special Allied Health Symposium on patient safety, a Endolumenal/NOTES® Symposium, a robotics panel, a forum and luncheon for surgical educators, and the SAGES Great Presidential Debates, a session dedicated to a broad range of issues including Universal Healthcare. Both Friday and Saturday's sessions are devoted to a range of engaging panels, concurrent sessions and keynote lectures. Dr. John Cameron will be delivering the Gerald Marks Lecture, "The Surgeon as a Role Model" on Friday with Dr. Catherine DeAngelis, Editor of JAMA, delivering the Health Policy Lecture on conflict of interest on Saturday.

SAGES Exhibits, Learning Center and Posters are open Thursday through Friday with the Poster session running until Saturday, April 25th.

Since 2005 the SAGES Scientific Session and Postgraduate Courses have been a part of Surgical Spring Week, a week of surgical meetings which have included the American College of Surgeons and the American Hepato-Pancreato Biliary Association. In 2009 SAGES meets once again with the International Pediatric Endosurgery Group (IPEG), the premiere international association for physicians who perform minimally invasive surgery in children. Several joint sessions have been incorporated into both programs including the joint panel, "Urgent and Emergent Acute Case Problems in Pediatric and Adult Patients" on Friday afternoon.

More information about the annual meeting and Surgical Spring Week is posted regularly on the SAGES website, http://www. sages. org/meetings/ (http://www. sages. org/meetings/). Interested parties may sign up for our e-newsletter by submitting an email address on the same site.

Questions should be directed to SAGES, 11300 W. Olympic Bvld., Suite 600, Los Angeles, CA 90064, Phone: 310-437-0544, Fax: 310-437-0585, Email: sagesweb (at) sages (dot) org

# # #

Thursday, January 5, 2006

Euroscreen Strengthens its Patent Position in the Field of Inflammatory Targets

Euroscreen Strengthens its Patent Position in the Field of Inflammatory Targets

European patent awarded for uses of Chemerin receptor and its natural ligand, both implicated in the control of physiological and pathological inflammatory reactions

Brussels, Belgium (PRWEB) November 9, 2005

Euroscreen SA, a world leader in G-protein-coupled receptors (GPCRs), today announced the issuance of a key European patent which protects the uses of Chemerin receptor and its natural ligand to find compounds that modulate its activity, and thus may have pharmaceutical potential.

The Chemerin receptor was cloned and characterized by the team of Professor Marc Parmentier at the Institute of Interdisciplinary Research (IRIBHM) of the Université Libre de Bruxelles. Their studies have shown that Chemerin receptor is mainly expressed on Dendritic Cells and Macrophages which are Antigen Presenting Cells (APCs), and that the natural ligand of Chemerin receptor (Chemerin) is a novel chemoattractant factor that specifically attracts APCs through this receptor. Recent data obtained at the IRIBHM strongly suggest that the central role played by APCs both in the initiation of immune responses and in the link between innate and adaptive immunity could be regulated by Chemerin receptor and its Chemerin ligand.

The European patent (1 405 083 B1) relates in particular to (i) screening methods to single out compounds that modulate, either up or down, the biological activity of Chemerin receptor, (ii) kit for screening agents that modulate the binding or the signaling activity of Chemerin receptor, (iii) kit for the diagnosis of a disease or disorder characterized by dysregulation of Chemerin receptor signaling, and (iv) the natural ligand of Chemerin receptor. The issuance of equivalent patents in the USA, Japan and Canada will occur in the near future.

Commenting on the announcement, Prof. Marc Parmentier, CSO and founder of Euroscreen, said: “This European patent award is a significant milestone in the positioning of Euroscreen as a GPCR company focused on inflammatory diseases and encourages us to pursue our efforts in internal drug discovery programs encompassing several inflammatory targets including the Chemerin receptor.”

For further information, please contact:

Euroscreen s. a. Tel: +32 71 348 500

Pierre Nokin, Ph. D.

President and CEO

Vincent Lannoy, Ph. D.

Business Development and Licensing Manager

About Euroscreen SA

Euroscreen is a world leader in G-protein coupled receptors (GPCRs). The Company integrates its research expertise in this area with its patented high-throughput AequoScreen™ cellular assay platform to patent new GPCR targets and drug candidates.

The Company is building its own patent portfolio of GPCR targets and novel drug leads for licensing to biopharmaceutical companies, and to date has agreements with Amersham/GE Healthcare, Cephalon, ChemDiv, Evotec, ICOS, Merck & Co, Pfizer Inc, Solvay, Syngenta and UCB. Euroscreen has also established collaborations with numerous academic centers for access to licenses to help in making available its broad menu of GPCR-based products (recombinant cell lines and membrane preparations) and services (custom screening and cloning).

Euroscreen has grown significant and strong patent positions to protect many key drug targets for licensing. Such patents include CCR5, Chemerin receptor, GPR43, GPR7/8, purinergic receptors (P2Y4, P2Y11 and P2Y13) and SHIP2 for type II diabetes. Euroscreen is able to offer intellectual property rights to companies for the development of therapeutic drugs that act through the above-mentioned targets. For more information regarding the Euroscreen’s portfolio, please contact Dr. Vincent Lannoy.

Euroscreen is a privately held company based in Brussels, Belgium with 80 employees of which 50 are in R&D.

###

Wednesday, January 4, 2006

Skilled Interim Leaders Turn Short-Term Vacancies into Long-Term Advantages--Healthcare Facilities See Improved Performance with Strategic Use of Interims

Skilled Interim Leaders Turn Short-Term Vacancies into Long-Term Advantages--Healthcare Facilities See Improved Performance with Strategic Use of Interims

When a key leader leaves a healthcare organization, it can affect financial, operational and clinical performance for months or even years, according to recent data gathered by the American College of Healthcare Executives. But in spite of its challenges, a leadership void presents an opportunity to leverage a skilled interim leader to take the organization to the next level.

Lenexa, KS (Vocus) October 15, 2009

When a key leader leaves a healthcare organization, it can affect financial, operational and clinical performance for months or even years, according to recent data gathered by the American College of Healthcare Executives. But in spite of its challenges, a leadership void presents an opportunity to leverage a skilled interim leader to take the organization to the next level.

“Hiring an interim who simply ‘fills the gap’ to keep the department functioning until a permanent leader can be found seems logical, but it contributes nothing to the positive momentum of the organization,” said Doug Smith, president and chief executive officer of healthcare leadership solutions and consulting firm B. E. Smith. “Healthcare executives are discovering that a top-performing interim leader can be an effective strategy for improving their business long term. Filling the gap is no longer satisfactory, nor should it be.”

A seasoned interim leader brings the ability to make an immediate and lasting impact on the organization in terms of improved financial, operational and clinical outcomes. Experience, while necessary, is only the starting point. “The right executive knows industry best practices and brings a knowledgeable, objective viewpoint backed by proven success in interim assignments,” Smith said. “He or she is not bound by organizational politics, and can focus on the objective at hand.”

In addition to meeting the organization’s day-to-day leadership needs during the vacancy, a strategic interim will begin by performing an exhaustive operational assessment to identify opportunities for improvement. This assessment is followed by a written action plan outlining concrete, implementable strategies that lay the groundwork for significant gains in performance. A high-performing interim also will implement short-term strategies prioritized by the organization, while developing a transition plan and long-term expert recommendations for his or her permanent successor. Finally, the leader will provide a means to measure the return-on-investment for their efforts, according to Smith.

Case in point: a 750-bed, not-for-profit hospital hired an interim director to fill a leadership void in their 80-bed emergency department. The results the interim director achieved were dramatic: emergency department turnaround time decreased from 255 minutes in October 2007 to 195 minutes a year later—despite a volume increase in 2008. What’s more, the “left without being seen” rate decreased from 10 percent in April 2008 to 1.5 percent in December 2008, while “arrival to bed placement” time decreased from 73 minutes in early 2008 to 24 minutes by October of the same year.

The strategic use of an interim leader also can succeed on the non-clinical side of the business. In one compelling example, a 500-bed tertiary hospital brought in an interim vice president of operations to fill a leadership void. Upon arrival, the interim leader focused on educating willing employees to cover additional areas of expertise. She also right-sized employee numbers, decreased supplies, reduced contract expenses and ceased operations where expenses exceeded revenues.

The results the hospital achieved far exceeded their expectations. In the first six months, the interim leader reduced overall expenses by $3 million and created a sustainable, positive bottom line. This was the first positive bottom line the hospital had experienced since being acquired by another healthcare organization.

“With the razor-thin margins healthcare organizations are experiencing today, executives need to ensure continued growth,” Smith said. “Innovative decision makers are using interim leaders to turn a short-term vacancy into a long-term advantage.”

To meet the rising demand for executive talent with the skills and credentials to strategically improve outcomes, healthcare organizations increasingly will rely on firms that employ their interim leaders in some capacity, said MaryAnn Digman, RN, B. S., MSHA, senior vice president of interim leadership for B. E. Smith.

“Working with firms that use the third-party employment model is safer and cost-effective. Interim leaders are employed by the firm, which manages their taxes, insurance and withholdings. This eliminates regulatory exposure for healthcare organizations,” she said. “The firm will supervise its interim leaders in the field, using performance goals clearly defined in the agreement to move the organization forward.”

About B. E. Smith:
Founded in 1978, B. E. Smith is a full-service leadership solutions firm for healthcare providers. B. E. Smith’s comprehensive suite of services includes Interim Leadership, Permanent Executive Placements and Consulting Solutions. The company is comprised of veteran healthcare leaders who partner with each client to create a solution that uniquely fits that client’s individual needs. In 2008, B. E. Smith placed more than 600 leaders into healthcare organizations worldwide. For more information, visit www. BESmith. com or call 877-802-4593.

SIDEBAR:

Case Study: Interim Leader Takes Emergency Department To Next Level

For Harris Regional Hospital in Sylva, N. C., the unexpected resignation of the emergency department leader came at a critical time. The department was getting ready to add six new exam rooms, while staff was working hard to maintain recent gains in patient satisfaction.

Chief Nurse Officer Sheila Price, BSN, RN, FACHE, called B. E. Smith, a healthcare leadership solutions and consulting firm that employs hospital executives who provide interim leadership services. “In healthcare, you can’t afford to go backwards,” Price said. “We felt this investment was critical to keeping forward momentum.”
A seasoned healthcare administrator with more than 15 years of nursing leadership experience, the interim leader from B. E. Smith started with a thorough assessment of the emergency department, identifying needs and providing a document with action steps, which were prioritized with Price’s help.

The interim took a number of steps to meet performance goals. She worked closely with physicians and staff to develop standardized treatment protocols based on nationwide best practices. Steps were taken to enhance the department’s data collection and analysis activities and improved processes were implemented, enabling Harris to use emergency department data to identify opportunities to improve the patient experience. And, she helped staff discover ways to use resources effectively and get patients care as quickly as possible.

She also implemented several solutions to operational issues. A new department schedule allotted shifts more fairly, effectively matching peak hours and focusing employees on the jobs they were hired for. Costs were contained by maintaining inventory at the lowest levels possible, as well as several low-cost equipment purchases that improved clinical efficiency. The interim leader then uncovered errors that resulted in lost revenue and created an easy-to-use scoring model to help nurses identify the right level of acuity. The system produces charges that are more accurate and more defensible if audited, according to Price.

A wide range of “people” issues also were addressed. A more effective orientation process for new staff improved retention, and the department’s charge nurse leadership structure was strengthened through a new, detailed job description. She then worked one-on-one with individuals to show them how to be more effective in their leadership roles.

According to Price, bringing in the interim leader was cost effective because it laid the groundwork for big gains in performance.

“For us, the payback has been dramatic,” she said. “Even after just two months, we already have a stronger foundation.”

###

Illinois Congresswoman Melissa Bean Discusses Collection Industry Issues with ACA International Member FMS Investment Corp

Illinois Congresswoman Melissa Bean Discusses Collection Industry Issues with ACA International Member FMS Investment Corp.

Congresswoman Melissa Bean, U. S. Representative to Illinois' Eighth Congressional District, visited the offices of FMS Investment Corp. during September 2009 to discuss various industry issues with the Company's executives. The visit was coordinated by ACA International, The Association of Credit and Collection Professionals, which selected FMS to represent the industry based on the company's reputation for providing innovative and citizen-centered services.

Schaumburg, Illinois (Vocus) September 29, 2009 -

Congresswoman Melissa Bean, U. S. Representative to Illinois' Eighth Congressional District, visited the offices of FMS Investment Corp. during September 2009 to discuss various industry issues with the Company's executives. The visit was coordinated by ACA International (http://www. acainternational. org), The Association of Credit and Collection Professionals, which selected FMS to represent the industry based on the company's reputation for providing innovative and citizen-centered services.

FMS is undergoing substantial growth in Schaumburg, IL as well as Rockford, IL, where the company recently opened a new 350-seat branch. So far in 2009, FMS has created 171 full-time jobs across both the company's Illinois locations, with an additional 140 positions expected by the end of 2010.

During a tour of FMS' Schaumburg headquarters, Representative Bean received an in-depth look at the company's government collection operations, which services defaulted, federally guaranteed student loans under contract with the U. S. Department of Education. Bean witnessed firsthand the reality of a modern, technologically driven collection operation, which is a far cry from the unfounded, negative stereotype of sweatshops filled with unscrupulous bill collectors. After meeting the dedicated and skilled staff, Rep. Bean thanked FMS employees and praised their role in the recovery of federal debt while ensuring the highest standards in citizen service.

Bean and the FMS executive team also discussed several legislative issues related to financial services and business regulation.

To conclude her visit to FMS, Bean addressed and answered questions from FMS employees, many of whom are her Eighth District constituents. During an outdoor lunch, Bean fielded questions regarding the rising cost of healthcare as well as funding for special education programs and the Arts in elementary and secondary education institutions. She also detailed key aspects of the Recovery Act and how this legislation would play a leading role in turning the economy around in coming months.

Bean commended FMS' growth and the substantial number of jobs created by the Company.

"We're happy to be recognized for realizing our long standing plans to expand and diversify as a company and also appreciate the opportunity to further the discussion on issues critical to the industry," said FMS President Balaji Rajan.

About ACA International (http://www. acainternational. org (http://www. acainternational. org))
ACA International, the Association of Credit and Collection Professionals, is the comprehensive, knowledge-based resource for success in the credit and collection industry. Founded in 1939, ACA brings together more than 5,500 members worldwide, including third-party collection agencies, asset buyers, attorneys, creditors and vendor affiliates. The association establishes ethical standards, produces a wide variety of products, services and publications, and articulates the value of the credit and collection industry to businesses, policymakers and consumers.

Media Contact: John Nemo, ACA International Public Relations Director, (952) 928-8000, ext. 124 or nemo at acainternational dot org

###

ItÂ’s Criminal, and TheyÂ’re Getting Away with Murder

ItÂ’s Criminal, and TheyÂ’re Getting Away with Murder

ItÂ’s criminal, and theyÂ’re getting away with murder! How many times have you said something like that when your health insurance company refuses to pay for a test or procedure you know should be covered? Bob Mitchell does when such a refusal leads to the death of his wife. Unlike the rest of us, however, he does more than just say it. Blue Vendetta, a 314-page legal thriller by Hugh Ellis, is the spell-binding tale of a courageous young public servant whose attempt to avenge the death of his wife pits him against powerful forces of greed lurking among those entrusted with the protection of our health, our well-being and our lives.

(PRWEB) October 13, 2003

Radford, Virginia (October 11, 2003) – It’s criminal, and they’re getting away with murder! How many times have you said something like that when your health insurance company refuses to pay for a test or procedure you know should be covered? Bob Mitchell does when such a refusal leads to the death of his wife. Unlike the rest of us, however, he does more than just say it. Blue Vendetta, a 314-page legal thriller by Hugh Ellis, is the spell-binding tale of a courageous young public servant whose attempt to avenge the death of his wife pits him against powerful forces of greed lurking among those entrusted with the protection of our health, our well-being and our lives.

As district attorney of Allen County, Ind., Mitchell charges the insurance company and its key executives with first degree murder. The pressure brought to bear on him by the insurance industry is immense, but his unwavering determination cannot be thwarted. A suspense-filled courtroom drama unfolds, and the surprise ending is guaranteed to catch the reader off-guard.

Blue Vendetta is a captivating, compelling and highly readable adventure about what happens when a powerful segment of society crosses the bounds of human decency.

Hugh Ellis, who wrote for pleasure throughout childhood, turned writing into a career within the last 10 years. He now lives in southern N. J. with his wife. His current projects include Shortcut, a sequel to the legal thriller Blue Vendetta, and a collection of short stories.

Branch & Vine Publishers, located in Virginia, was started in 1995 and reformed as a LLC in January 2003. Two published authors formed Branch & Vine, which started as a small bulletin to promote their books and quickly evolved into a publishing company with several imprints. The imprints include two science fiction (Otherworlds Sci-Fi & Anvil-Mace) and one print on demand-POD (Ajalon Press). Branch & Vine seeks new voices in literature because they recognize the difficulties in gaining the attention of large publishing companies. All genres are accepted, except books based on hate or that are overly violent, sexual or demonic. Visit www. branchandvinepublishers. com or www. AjalonPress. com for more information.

ISBN#: 1-57688-030-3

Format: Trade Paperback 5.5 x 8.5

Pages: 314

Publisher: Branch & Vine Publishers, LLC

Friday, December 30, 2005

New Report from WTRS Finds Uncertain Future for INSTEON Technology

New Report from WTRS Finds Uncertain Future for INSTEON Technology

WTRS reevaluates the future of INSTEON and compares it with competition from ZigBee, Z-Wave, X-10 and UPB, in new Report: "WTRS December 2007 INSTEON Emerging Technology Report."

Mountain View, CA (PRWEB) December 19, 2007

INSTEON Technology developed by SmartLabs Inc. has the potential to revolutionize the Home Control industry by providing solutions that address the large mid-range consumer market that is largely untapped due to a number of factors including a lack of consumer demand and understanding for the technology. Due to business decisions independent of the technology, the
Future of INSTEON faces much uncertainty.

WTRS has today released the "December 2007 INSTEON Emerging Technology Report." Our research shows that the INSTEON Technology enjoys a high level of interest in the broader electronics products industry," according to Kirsten West PhD, Principal Analyst with WTRS. "A lack of consistent investment in product and OEM support by SmartLabs places this momentum at risk."

Reflecting this risk the just completed report from WTRS examines the strategic options facing SmartLabs and other INSTEON adopters. The report includes market adoption forecasts that are based on the assumptions and potential outcomes of these strategies.

Report Findings:

. The report identifies the factors driving market growth including the recent turmoil in the US housing market.

. Provides an analysis of the Strengths, Weaknesses, Opportunities, and Threats (SWOT) of the INSTEON Alliance.

. Includes market forecasts for INSTEON in the home automation market, including segmentation in home control, landscaping, and healthcare.

. Analyzes the relative technical strengths and weaknesses of INSTEON as compared with ZigBee, Z-Wave, x-10, and UPB.

. Summarizes patent activity surrounding INSTEON technology.

. Offers an analysis of the INSTEON Alliance as well as other INSTEON adopters.

. Finally, the report provides an analysis of the market opportunity for INSTEON and other Home Control technologies in the US market.

The "WTRS December 2007 INSTEON Emerging Technology Report" is available directly from www. wtrs. net, or by calling 650 940-1196.

WTRS (West Technology Research Solutions) is a California based research, publishing and consulting company providing the leading viewpoint on emerging wireless technologies, markets and applications. With an eight-year record of successful growth, we're ready to help your company make market decisions and plan for the future. www. wtrs. net

###